GGrantIndex
← Search

Molecular Modeling Facility

$16,629P30FY2025CANIH

Research Inst Of Fox Chase Can Ctr, Philadelphia PA

Investigators

Linked publications, trials & patents

Paper 39604567Paper 39602533Paper 39554190Paper 39546469Paper 39521739Paper 39514554Paper 39371220Paper 39345610Paper 39343653Paper 39223207Paper 39207123Paper 39189642Paper 39148468Paper 39137728Paper 39072643Paper 39060143Paper 39013784Paper 39003201Paper 38982062Paper 38976159Paper 38963567Paper 38914477Paper 38871720Paper 38865671Paper 38853421Paper 38835516Paper 38815457Paper 38811332Paper 38798370Paper 38766032Paper 38747616Paper 38678525Paper 38659828Paper 38639476Paper 38638131Paper 38600381Paper 38586274Paper 38586042Paper 38559274Paper 38547779Paper 38539515Paper 38464238Paper 38452871Paper 38432028Paper 38421650Paper 38377387Trial NCT04290585Trial NCT03177057Trial NCT02594826Trial NCT02132884Trial NCT02132858Trial NCT02132845Trial NCT02110953Trial NCT02092714Trial NCT02050009Trial NCT01982591Trial NCT01962948Trial NCT01934179Trial NCT01840150Trial NCT01462630Trial NCT01316757Trial NCT01212822Trial NCT00750009Trial NCT00509626Trial NCT00458588Trial NCT00436397Trial NCT00433524Trial NCT00084591Trial NCT00084539Trial NCT00084526Trial NCT00084513Trial NCT00066677Trial NCT00062322Trial NCT00062309Trial NCT00043108Trial NCT00039520Trial NCT00039507Trial NCT00022308Trial NCT00021398Trial NCT00021372Trial NCT00021346Trial NCT00021333Trial NCT00021320Trial NCT00005037Trial NCT00003264Trial NCT00003263Trial NCT00003109Patent 9533040Patent 9182383Patent 9101603Patent 8980258Patent 8685658Patent 8609437Patent 8580263Patent 8329873Patent 7332585Patent 7332580Patent 7129057Patent 6946275Patent 6617427

Abstract

PROJECT SUMMARY/ABSTRACT – SHARED RESOURCE: MOLECULAR MODELING FACILITY The goal of the Molecular Modeling Facility (MMF) is to provide FCCC members with structural information for proteins and protein complexes to enable the generation of mechanistic hypotheses in cancer biology, prevention, and therapeutic development. The MMF derives structural information from the Protein Data Bank (PDB) and the application of deep learning structure prediction methods such as DeepMind’s AlphaFold2 and AlphaFold-Multimer. The MMF identifies relevant experimental structures from bioinformatics tools developed in the Dunbrack lab and elsewhere. In the last two years, the accuracy of protein structure prediction has increased substantially. Previously molecular modeling relied on structure prediction by homology, which is dependent on the availability of experimental structures related to the target(s). Now, with AlphaFold2, it is possible for the MMF to predict the structures of the folded regions of almost all human proteins and those of relevant model organisms to near experimental accuracy. Even more important, AlphaFold-Multimer can predict structures of stable multi-protein complexes with high accuracy, guiding testable hypotheses on protein-protein interactions in cancer-relevant molecular pathways. In cancer genetics, the MMF utilizes experimental and computationally derived structures of proteins and proteins complexes to assist investigators in the interpretation of mutations observed in patient samples. As the field of deep-learning based structure prediction and protein design evolves, the MMF will continue to incorporate new methods in our computational pipelines and will develop high- throughput computational screening of protein-protein interactions and mutation assessments. The facility provided service to 18 FCCC members for the 12 months ending 10/31/23. Several of the projects required months of effort and comprised substantial portions of the relevant manuscripts. Table 2 further illustrates the number of peer reviewed users by services offered by the MMF. For the 12 months ending 10/31/23, 347 direct service hours (99% of the total hours billed) were performed for Peer-Review Funded FCCC members. The MMF was utilized by 30 FCCC Members and essential to all three Programs in 2019-2023 (through October). The MMF is advised by a dedicated Facility Advisory Committee (FAC) that meets annually. Recommendations from the FAC are directed to a governing Facility Parent Oversight Committee that advises Senior Leadership to ensure that the MMF continues to have the necessary resources to provide the highest quality services for FCCC members.

View original record on NIH RePORTER →